Royce & Associates’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Royce & Associates’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$359K	–	1086
2020 Q4	$359K	Hold	10,000	–	–	﹤0.01%	926
2020 Q3	$380K	Hold	10,000	–	–	﹤0.01%	886
2020 Q2	$350K	Hold	10,000	–	–	﹤0.01%	891
2020 Q1	$345K	Hold	10,000	–	–	﹤0.01%	874
2019 Q4	$332K	Hold	10,000	–	–	﹤0.01%	932
2019 Q3	$254K	Hold	10,000	–	–	﹤0.01%	966
2019 Q2	$216K	Hold	10,000	–	–	﹤0.01%	988
2019 Q1	$170K	Hold	10,000	–	–	﹤0.01%	1003
2018 Q4	$116K	Hold	10,000	–	–	﹤0.01%	998
2018 Q3	$165K	Hold	10,000	–	–	﹤0.01%	1022
2018 Q2	$127K	Hold	10,000	–	–	﹤0.01%	1068
2018 Q1	$150K	Hold	10,000	–	–	﹤0.01%	1098
2017 Q4	$136K	Sell	10,000 -50,000	-83%	-$785K	﹤0.01%	1095
2017 Q3	$1.15M	Buy	+60,000	New	+$1.13M	0.01%	925

Other funds holding ZEAL

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Royce & Associates's ZEAL Position: Q1 2021 in Review

Royce & Associates sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q1 2021, closing a stake of 10,000 shares — an estimated $359K sold.

Royce & Associates first reported a position in ZEAL in Q3 2017 and held it in 14 quarters. The position peaked at $1.15M in Q3 2017. 16 funds tracked by Wall St. Rank hold ZEAL as of Q1 2021.

Royce & Associates reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Royce & Associates sold 10,000 Zealand Pharma A/S American Depositary Shares shares in Q1 2021, an estimated $359K.
Royce & Associates first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 14 quarters.
Royce & Associates's Zealand Pharma A/S American Depositary Shares position peaked at $1.15M in Q3 2017.
16 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q1 2021.

Based on Royce & Associates's 13F filing for Q1 2021, filed 10 May 2021.